Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
Abstract Background The benefits and risks of antiplatelet therapy for patients with chronic kidney disease (CKD) remain controversial. We undertook a systematic review and meta-analysis to investigate the effects of antiplatelet therapy on major clinical outcomes. Methods We systematically searched...
Main Authors: | Xiaole Su, Bingjuan Yan, Lihua Wang, Jicheng Lv, Hong Cheng, Yipu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-019-1499-3 |
Similar Items
-
Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial
by: Jiachuan Xiong, et al.
Published: (2021-01-01) -
Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease
by: İbrahim Yıldız, et al.
Published: (2014-07-01) -
Evaluating Effectiveness and Safety in Chronic Kidney Disease with Atrial Flutter Using an Anticoagulation Strategy
by: Ying-Ting Wang, et al.
Published: (2020-05-01) -
P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
by: Sohyun Park, et al.
Published: (2021-03-01) -
Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease—A Systematic Review and Meta-Analysis
by: Yao Hu, et al.
Published: (2020-10-01)